The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $57.18

Today's change0.00 0.00%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $57.18

Today's change0.00 0.00%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

ResMed Inc closed at (U.S.)$57.18.

Over the last five days, shares are unchanged, but have gained 6.50% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $57.18
  • High--
  • Low--
  • Bid / Ask(U.S.) $50.55 / (U.S.) $57.75
  • YTD % change+6.50%
  • Volume0
  • Average volume (10-day)1,314,458
  • Average volume (1-month)1,338,955
  • Average volume (3-month)1,042,555
  • 52-week range(U.S.) $48.99 to (U.S.) $75.33
  • Beta0.68
  • Trailing P/E23.27×
  • P/E 1 year forward21.34×
  • Forward PEG2.33×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield2.10%
  • Trailing EPS(U.S.) $2.46
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+20.06%

Based on its net profit margin of 20.06%, ResMed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue455412453422
Total other revenue--------
Total revenue455412453422
Gross profit267239259251
Total cost of revenue188173194171
Total operating expense347314354317
Selling / general / administrative118111129116
Research & development29272927
Depreciation / amortization4222
Interest expense (income), net operating--------
Unusual expense (income)7--0--
Other operating expenses, total--------
Operating income10898100106
Interest income (expense), net non-operating-----6--
Gain (loss) on sale of assets--------
Other--------
Income before tax11499104114
Income after tax91808791
Income tax, total23191723
Net income91808791
Total adjustments to net income--------
Net income before extra. items91808791
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items91808791
Inc. avail. to common incl. extra. items91808791
Diluted net income91808791
Dilution adjustment--------
Diluted weighted average shares141142143143
Diluted EPS excluding extraordinary itemsvalue per share0.640.570.610.64
Dividends per sharevalue per share0.300.300.280.28
Diluted normalized EPSvalue per share0.680.570.610.64